Liabilities of Zenas BioPharma, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary: Zenas BioPharma, Inc. quarterly Liabilities in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
Zenas BioPharma, Inc. Liabilities for the quarter ending 30 Sep 2025 was $125,590,000, a 185% increase year-over-year.
Source SEC data: View on sec.gov

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Change (%)

Zenas BioPharma, Inc. Quarterly Liabilities (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$125,590,000	+$81,593,000	+185%	30 Sep 2025	10-Q	12 Nov 2025	2025	Q3
Q2 2025	$53,459,000			30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q1 2025	$49,449,000			31 Mar 2025	10-Q	15 May 2025	2025	Q1
Q4 2024	$57,510,000	+$13,695,000	+31%	31 Dec 2024	10-Q	12 Nov 2025	2025	Q3
Q3 2024	$43,997,000			30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q4 2023	$43,815,000			31 Dec 2023	10-K	11 Mar 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.